References
- 1. Ferlay J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127:2893-2917.
- 2. Correa P, Piazuelo M. The Gastric Precancerous Cascade. J Clin Exp Pathol. 2013;3 (3):147.
- 3. Lauren P.The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand.1965;64: 31-49.
- 4. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-first American Cancer Society award lecture on cancer epidemiology and prevention.Cancer research.1992;52:6735-6740.
- 5. González CA, Agudo A. Carcinogenesis, prevention and early detection of gastric cancer: where we are and where we should go. Int J Cancer. 2012;130:745-753.
- 6. Zullo A, Hassan C, Romiti A, Giusto M, Guerriero C, Lorenzetti R, Campo SM, Tomao S. Follow-up of intestinal metaplasia in the stomach: When, how and why. World J Gastrointest Oncol. 2012;4:30-36.
- 7. Whiting JL, Sigurdsson A, Rowlands DC, Hallissey MT, Fielding JW. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut. 2002;50:378-381.
- 8. Park YH, Kim N. Review of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer. J Cancer Prev. 2015; 20:25-40.
- 9. Craanen, M. E.,Dekker W, Blok P et al. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut. 1992;33:16-20.
- 10. Joo YE, Park HK, Myung DS et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea. Gut Liver.2013;7:303-310.
- 11. Zullo A, Gatta L, De Francesco V, et al. High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study. Aliment Pharmacol Ther. 2005;21:1419-1424.
- 12. Tulassay Z, Stolte M, Engstrand L, et al. Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers. Scand J Gastroenterol. 2010;45:1048-1058.
- 13. Leung WK, Lin SR, Ching JY, et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut. 2004;53:1244-1249.
- 14. Eshmuratov A, Nah JC, Kim N, et al. The correlation of endoscopic and histologic
- 15. Den Hoed C. M., B.C. van Eijck, L.G. Capelle, et al. The prevalence of premalignant gastric lesions in asymptomatic patients: predicting the future incidence of gastric cancer. Eur J Cancer. 2011;47:1211-1218.
- 16. Sonnenberg A, Lash RH, Genta RM. A national study of Helicobactor pylori infection in gastric biopsy specimens.Gastroenterology. 2010;139:1894-1901.
- 17. Conteduca V, Sansonno D, Lauletta G, et al. H. pylori infection and gastric cancer: State of the art (Review). Int J Oncol. 2013;42:5-18.
- 18. Valle J, Gisbert JP. Helicobacter pylori infection and precancerous lesions of the stomach. Hepato-gastroenterology. 2000;48:1548-1551.
- 19. Haziri A, Juniku-Shkololli A, Gashi Z, et al. Helicobacter pylori infection and precancerous lesions of the stomach. Med Arh. 2010;64:248-249.
- 20. Zhang C, Yamada N, Wu YL, et al. Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World J Gastroenterol. 2005;11:791-796.
- 21. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988;48:3554-3560.
- 22. Rozen P. Cancer of the gastrointestinal tract: early detection or early prevention? Eur J Cancer Prev. 2004;13:71-75.
- 23. Israel DA, Peek RM. Review article: pathogenesis of Helicobacter pyloriinduced gastric inflammation. Aliment Pharmacol Ther. 2011;15:1271-1290.